Androgen receptor phosphorylation at serine 308 and serine 791 predicts enhanced survival in castrate resistant prostate cancer patients.

International journal of molecular sciences

Volumn 14, Issue 8, 2013, Pages 16656-16671

  McCall, Pamela ^a   Adams, Claire E ^b   Willder, Jennifer M ^b   Bennett, Lindsay ^b   Qayyum, Tahir ^b   Orange, Clare ^b   Underwood, Mark A ^b   Edwards, Joanne ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; AR PROTEIN, HUMAN;

CASTRATION RESISTANT PROSTATE CANCER; CELL PROLIFERATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MORTALITY; PHOSPHORYLATION; SURVIVAL; TUMOR RECURRENCE;

CELL PROLIFERATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM RECURRENCE, LOCAL; PHOSPHORYLATION; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; RECEPTORS, ANDROGEN; SURVIVAL;

EID: 84897365872     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140816656     Document Type: Article

References (0)